Scinovex
article Open AccessTop 10% cited

Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update

British Journal of Haematology · 2011 · Vol. 156(1) · pp. 37–49
Paula Bolton‐MaggsJacob C. LangerAchille IolasconPaul TittensorMay‐Jean King

Abstract

Guidelines on hereditary spherocytosis (HS) published in 2004 (Bolton-Maggs et al, 2004) are here replaced to reflect changes in current opinion on the surgical management, (particularly the indications for concomitant splenectomy with cholecystectomy in children with mild HS, and concomitant cholecystectomy with splenectomy in those with asymptomatic gallstones). Further potential long term hazards of splenectomy are now recognised. Advances have been made in our understanding of the biochemistry of the red cell membrane which underpins the choice of tests. Biochemical assays of membranes proteins and genetic analysis may be indicated (rarely) to diagnose atypical cases. The diagnostic value of the eosin-5-maleimide (EMA) binding test has been validated in a number of studies with understanding of its limitations.

Erythrocyte Function and PathophysiologyNeonatal Health and BiochemistryHemoglobinopathies and Related DisordersHereditary spherocytosisSplenectomyAsymptomaticSpherocytosisConcomitantMedicineGallstonesGeneral surgeryPathologySurgery

MeSH terms

HumansSpherocytosis, Hereditary

Funding

  • British Society for Haematology
Citations
385
FWCI
8.14
field-weighted impact
References
93
Percentile
98%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update · Scinovex